期刊文献+

甲基喹啉酮乙酸类化合物的合成及其醛糖还原酶抑制活性 被引量:2

Synthesis and aldose reductase inhibitory activities of methylquinolinoneacetic acids
原文传递
导出
摘要 目的合成甲基喹啉酮乙酸类化合物,并评价其对醛糖还原酶的抑制活性。方法以甲基苯胺为起始原料,经加成、水解、环合、烃化、缩合、水解6步反应得到相应的目标化合物。以依帕司他为阳性对照药,采用大鼠晶状体醛糖还原酶对目标化合物醛糖还原酶抑制活性进行初步评价。结果合成了26个目标化合物,均未见文献报道,目标化合物的结构经核磁共振氢谱和红外光谱确证;6-甲基系列化合物活性均较好,特别是化合物Ⅵ6(IC50=0.088μmol.L-1)活性最好,与依帕司他相当;8-甲基系列化合物活性较弱,只有化合物Ⅵ15和Ⅵ23活性相对较好,IC50值分别为3.379、3.055μmol.L-1。结论甲基喹啉酮乙酸类化合物作为新型醛糖还原酶抑制剂,其构效关系值得进一步研究。 Aim To synthesize methylquinolinoneacetic acids, and to assay their inhibitory activities against aldose reductase(AR). Methods The methylquinolinoneacetic acids were synthesized via addition,hydrolysis, cyclization, alkylation, condensation, and hydrolysis, a six-step procedure starting from methyl substituted aniline. Using epalrestat as a control, the aldose reductase inhibitory activities of the compounds obtained were evaluated on rat lens aldose reductase in vitro. Results Twenty-six compounds were obtained and all of them were not reported yet, and their structures were characterized by ^1H-NMR and IR. Among the compounds tested, 6-methylquinolinoneacetic acids show good activities, and compound Ⅵ6 (IC50 = 0. 088 umol·L^- 1 )exhibits the best activity, which is comparable with epalrestat ;however,8-methylquinolinoneacefic acids are relatively weaker,only compounds Ⅵ15 and Ⅵ23 exert significant activities,the IC50 is 3. 379 and 3. 055 umol.L^-1 each. Conclusion The structure-activity relationships of methylquinolinoneacetic acids, as a novel type of aldose reductasc inhibitor, should be investigated further.
出处 《中国药物化学杂志》 CAS CSCD 2009年第1期7-14,共8页 Chinese Journal of Medicinal Chemistry
关键词 构效关系 化学合成 醛糖还原酶抑制剂 甲基喹啉酮乙酸 structure-activity relationship chemical synthesis aldose reductase inhibitor methylquinolinoneacetic acids
  • 相关文献

参考文献12

  • 1罗雯.糖尿病并发抑郁症研究进展[J].实用中医内科杂志,2006,20(5):459-460. 被引量:12
  • 2廖二元 超楚生.内分泌学[M].北京:人民卫生出版社,2001.610-611.
  • 3COATANTINO L, RASTELLI G, VIANELLO P, et al. Diabetes complications and their potential prevention:aldose reductase inhibition and other approaches [ J]. Med Res Rev, 1999,19( 1 ) :3 - 23.
  • 4FEDERICO D S, GIAMPAOLO P, ANTONIO D S, et al. Novel, highly potent aldose reductase inhibitors : cyano ( 2-oxo-2,3-dihydroindol-3-y 1 ) acetic acid derivatives [ J]. J Med Chem, 2003, 46 (8): 1419 - 1428.
  • 5EI-KABBANI O,RUIZ F,DARMANIN C,et al. AIdose reductase structures:implications for mechanism and inhibition [ J]. Cell Mol Life Sci, 2004,61 ( 7/ 8) :750 -762.
  • 6KLEBE G, KRAMER O, SOTRIFFER C. Strategies for the design of inhibitors of aldose reductase, an enzyme showing pronounced induced-fit adaptations [ J ]. Cell Mol Life Sci,2004,61 (7/8) : 783 - 793.
  • 7KAORU A,MASATO T,HIDEO H,et al. Isoliquiritigenin: a new aldose reductase inhibitor from Gly- cyrrhizae radix [ J ]. Planta Med, 1990, 56 ( 3 ) : 254 - 258.
  • 8LIM SS, JUNG SH, JI J, et al. Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues [ J]. J Pharm Pharmacol, 2001,53 ( 5 ) : 653 - 668.
  • 9URZHUMTSEV A, TETE-FAVIER F, MITSCHLER S,et al. A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil [ J ]. Structure, 1997, 5 (5): 601 -612.
  • 10MERCHANT J R, CHOTHIA D S. Reactions of nitriles, part VIII. Synthesis of 2, 3-dihydroquinolin-4 (1H)-ones [ J]. J Chem Soc: Perkin I, 1972,7: 932 - 935.

二级参考文献17

  • 1姚军,吴文源,李春波.糖尿病伴发抑郁症临床初步研究[J].上海精神医学,2003,15(z1):14-16. 被引量:15
  • 2周连华,周湘兰,施晓红,任风东.2型糖尿病合并抑郁症分析[J].中国临床医学,2004,11(6):1127-1128. 被引量:45
  • 3石井均.糖尿病心理行动学的诸问题[J].糖尿病,2000,43:1319-1319.
  • 4Lustman PJ,et al; Semin Clin Neuropsychiatry,1998; 3(2):102~114.
  • 5Thomas J,Jones G,Scarinci I,etal.A descriptive and comparative study of the prevalence of depressive and anxiety discorders in low-in come adults with type 2 diabetes and other chronic illnesses.Diabetes Care,2003,26(8):2311~2317.
  • 6Sevincok L,Guney E,Uslu A,etal.Depression in a sample of Turk is type 2 diabetes patients.Eur Psychiatry,2001,16(4):229~231.
  • 7Harik DE.Patterns of emotional reations after a myocardial infanction.J Psychosom Res,1990,34:271
  • 8Garvard JA,Lustman PJ,Clouse RE.Prevalence of depression in adults with diabetes:an epidemiological evaluation.Diabetes Care,1993,16:116-117.
  • 9Peyrot M,RubinR R.Level sand risks of depression and anxiety symptom atology among diabetes adults.Diabetes Care,1997,20:585-590.
  • 10Eaton WW,Armenian H,Gallo J,etal.Depression and risk for onset oftypeⅡdiabtes.Aprospective population based study[J].Diabetes Care,1996,19:1097 1102.

共引文献675

同被引文献14

  • 1COATANTINO L,RASTELLI G,VIANELLO P,et al.Diabetes complications and their potential prevention:aldose reductase inhibition and other approaches[J].Med Res Rev,1999,19(1):3-23.
  • 2FEDERICO D S,GIAMPAOLO P,ANTONIO D S,et al.Novel,highly potent aldose reductase inhibitors:cyano(2-oxo-2,3-dihydroindol-3-y1)acetic acid derivatives[J].J Med Chem,2003,46(8):1419-1428.
  • 3LIM S S,JUNG S H,JI J,et al.Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues[J].J Pharm Pharmacol,2001,53(5):653-668.
  • 4URZHUMTSEV A,TETE-FAVIER F,MITSCHLER A,et al.A‘specificity’pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil[J].Struct,1997,5(5):601-612.
  • 5王绍杰.喹啉酮乙酸类化合物的设计、合成及醛糖还原酶抑制活性研究[D].沈阳:沈阳药科大学,2007.
  • 6王绍杰,晏菊芳,吴静,等.具有醛糖还原酶抑制活性的4-氧代-1(4H)-喹啉羧酸类化合物、组合物及其制备方法:CN,200710011464.2[P].2007-10-24.
  • 7ELDERFIELD R C,GENSLER W J,BEMBRY T H,et al.Experiments on the synthesis of 4-hydroxy-and4-chloroquinolines fromβ-anilinopropionic acids[J].J Pharm Pharmacol,1946,68(7):1259-1263.
  • 8ROBERT G,SCHMIDT E K,BAYBURT E K,et al.Chroman and tetrahydroquinoline ureas as potent TRPV1 antagonists[J].Bioorg Med Chem Lett,2011,21(5):1338-1341.
  • 9DOLITZKY B Z,MENDELOVICI M,NIDAM T,et al.Processes for preparing 6-hydroxy-3,4-dihydroquinolinone,cilostazol and N-(4-methoxyphenyl)-3-chloropropionamide:US,20020032333[P].2001-03-20.
  • 10高畑廣紀,大西義章,竹原広幸,等.A convenient synthesis of monocyclicβ-lactams by means of solidliquid phase transfer reactions[J].Chemical&Pharmaceutical Bulletin,1981,29(4):1063-1068.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部